| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 255.469 | 271.499 | 288.936 | 277.053 | 312.534 | 212.569 | 281.134 | 80.867 | 1.154 | 6.477 |
| Total Income - EUR | 268.315 | 282.160 | 300.618 | 286.345 | 318.648 | 242.434 | 298.442 | 85.132 | 8.980 | 6.477 |
| Total Expenses - EUR | 205.339 | 220.887 | 253.240 | 220.915 | 255.401 | 229.942 | 270.785 | 108.125 | 26.503 | 16.730 |
| Gross Profit/Loss - EUR | 62.976 | 61.273 | 47.378 | 65.430 | 63.247 | 12.492 | 27.656 | -22.993 | -17.523 | -10.253 |
| Net Profit/Loss - EUR | 52.900 | 51.452 | 44.353 | 62.614 | 60.114 | 11.253 | 25.178 | -23.718 | -17.619 | -10.319 |
| Employees | 15 | 15 | 14 | 13 | 13 | 15 | 14 | 8 | 1 | 1 |
Check the financial reports for the company - Biochange S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 31.893 | 21.395 | 15.007 | 25.422 | 16.933 | 16.425 | 14.050 | 10.002 | 8.528 | 7.981 |
| Current Assets | 71.523 | 41.848 | 37.199 | 45.193 | 50.415 | 28.721 | 35.057 | 4.526 | 7.021 | 2.690 |
| Inventories | 7.926 | 8.988 | 7.248 | 6.848 | 7.557 | 5.846 | 7.339 | 0 | 3.899 | 2.434 |
| Receivables | 0 | 413 | 1.759 | 567 | 0 | 0 | 2.511 | 2.350 | 2.574 | 0 |
| Cash | 63.597 | 32.447 | 28.192 | 37.778 | 42.858 | 22.874 | 25.207 | 2.176 | 549 | 256 |
| Shareholders Funds | 94.602 | 51.505 | 44.406 | 62.666 | 60.165 | 11.303 | 36.230 | 12.625 | -5.032 | -15.323 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 8.814 | 11.738 | 7.801 | 7.950 | 7.183 | 33.843 | 12.877 | 1.903 | 20.581 | 25.994 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "9604 - 9604" | |||||||||
| CAEN Financial Year |
9604
|
|||||||||
Comments - Biochange S.r.l.